Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Statement of Comprehensive Income

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Biogen Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net income
Unrealized gains (losses) on securities available for sale, net of tax
Unrealized gains (losses) on cash flow hedges, net of tax
Gains (losses) on net investment hedges, net of tax
Unrealized gains (losses) on pension benefit obligation, net of tax
Currency translation adjustment
Other comprehensive income (loss) attributable to noncontrolling interests, net of tax
Other comprehensive income (loss), net of tax
Comprehensive income
Comprehensive (income) loss attributable to noncontrolling interests, net of tax
Comprehensive income attributable to Biogen Inc.

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Comprehensive income item Description The company
Net income attributable to Biogen Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Biogen Inc. net income attributable to Biogen Inc. decreased from 2019 to 2020 and from 2020 to 2021.
Comprehensive income attributable to Biogen Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Biogen Inc. comprehensive income attributable to Biogen Inc. decreased from 2019 to 2020 and from 2020 to 2021.